Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CTI-BIOPHARMA-CORP-16603771/news/CTI-BioPharma-Announces-Publication-In-Blood-Of-Phase-2-Results-Of-Pacritinib-In-Patients-With-Mye-20031530/?utm_source=whatsapp&utm_medium=social&utm_campaign=share